These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19634138)

  • 1. Role of microRNA in anticancer drug resistance.
    Zheng T; Wang J; Chen X; Liu L
    Int J Cancer; 2010 Jan; 126(1):2-10. PubMed ID: 19634138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of long non-coding RNA in tumor drug resistance.
    Deng H; Zhang J; Shi J; Guo Z; He C; Ding L; Tang JH; Hou Y
    Tumour Biol; 2016 Sep; 37(9):11623-11631. PubMed ID: 27380056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA and drug resistance.
    Ma J; Dong C; Ji C
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and cancer resistance: A new molecular plot.
    Fanini F; Fabbri M
    Clin Pharmacol Ther; 2016 May; 99(5):485-93. PubMed ID: 26875151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as new therapeutic targets and tools in cancer.
    Gandellini P; Profumo V; Folini M; Zaffaroni N
    Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-130a in cancer.
    Zhang HD; Jiang LH; Sun DW; Li J; Ji ZL
    Breast Cancer; 2017 Jul; 24(4):521-527. PubMed ID: 28477068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA.
    Li XJ; Zha QB; Ren ZJ; Tang JH; Yao YF
    Curr Opin Oncol; 2015 Nov; 27(6):457-65. PubMed ID: 26371779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A; Miller JH
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
    Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of micro-RNAs in drug resistance of multiple myeloma.
    Abdi J; Jian H; Chang H
    Oncotarget; 2016 Sep; 7(37):60723-60735. PubMed ID: 27494872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
    Xu K; Liang X; Cui D; Wu Y; Shi W; Liu J
    Mol Carcinog; 2013 Jan; 52(1):70-8. PubMed ID: 22121083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.